BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang P, Wang L, Li Q, Tian X, Xu J, Xu J, Xiong Y, Chen G, Qian H, Jin C, Yu Y, Cheng K, Qian L, Yang Y. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res 2020;116:353-67. [PMID: 31119268 DOI: 10.1093/cvr/cvz139] [Cited by in Crossref: 99] [Cited by in F6Publishing: 118] [Article Influence: 33.0] [Reference Citation Analysis]
Number Citing Articles
1 Pu Y, Li C, Qi X, Xu R, Dong L, Jiang Y, Gong Q, Wang D, Cheng R, Zhang C, Chen Y. Extracellular Vesicles from NMN Preconditioned Mesenchymal Stem Cells Ameliorated Myocardial Infarction via miR-210-3p Promoted Angiogenesis. Stem Cell Rev Rep 2023. [PMID: 36696015 DOI: 10.1007/s12015-022-10499-6] [Reference Citation Analysis]
2 Emami Meybodi SM, Soleimani N, Yari A, Javadifar A, Tollabi M, Karimi B, Emami Meybodi M, Seyedhossaini S, Brouki Milan P, Dehghani Firoozabadi A. Circulatory long noncoding RNAs (circulatory-LNC-RNAs) as novel biomarkers and therapeutic targets in cardiovascular diseases: Implications for cardiovascular diseases complications. Int J Biol Macromol 2023;225:1049-71. [PMID: 36414082 DOI: 10.1016/j.ijbiomac.2022.11.167] [Reference Citation Analysis]
3 Qiu J, Liu XJ, You BA, Ren N, Liu H. Application of Nanomaterials in Stem Cell-Based Therapeutics for Cardiac Repair and Regeneration. Small 2023;:e2206487. [PMID: 36642861 DOI: 10.1002/smll.202206487] [Reference Citation Analysis]
4 Dang Y, Hua W, Zhang X, Sun H, Zhang Y, Yu B, Wang S, Zhang M, Kong Z, Pan D, Chen Y, Li S, Yuan L, Reinhardt JD, Lu X, Zheng Y. Anti-angiogenic effect of exo-LncRNA TUG1 in myocardial infarction and modulation by remote ischemic conditioning. Basic Res Cardiol 2023;118:1. [PMID: 36635484 DOI: 10.1007/s00395-022-00975-y] [Reference Citation Analysis]
5 Yin X, Jiang LH. Extracellular vesicles: Targeting the heart. Front Cardiovasc Med 2022;9:1041481. [PMID: 36704471 DOI: 10.3389/fcvm.2022.1041481] [Reference Citation Analysis]
6 Chang W, Li P. Bone marrow mesenchymal stromal cell-derived small extracellular vesicles: A novel therapeutic agent in ischemic heart diseases. Front Pharmacol 2022;13:1098634. [PMID: 36686710 DOI: 10.3389/fphar.2022.1098634] [Reference Citation Analysis]
7 Feng Q, Zhang Y, Fang Y, Kong X, He Z, Ji J, Yang X, Zhai G. Research progress of exosomes as drug carriers in cancer and inflammation. J Drug Target 2023;:1-19. [PMID: 36543743 DOI: 10.1080/1061186X.2022.2162059] [Reference Citation Analysis]
8 Li H, Gu J, Sun X, Zuo Q, Li B, Gu X. Isolation of Swine Bone Marrow Lin-/CD45-/CD133 + Cells and Cardio-protective Effects of its Exosomes. Stem Cell Rev Rep 2023;19:213-29. [PMID: 35925437 DOI: 10.1007/s12015-022-10432-x] [Reference Citation Analysis]
9 Vilaça A, de Windt LJ, Fernandes H, Ferreira L. Strategies and challenges for non-viral delivery of non-coding RNAs to the heart. Trends Mol Med 2023;29:70-91. [PMID: 36371335 DOI: 10.1016/j.molmed.2022.10.002] [Reference Citation Analysis]
10 Semedo-kuriki P, Pereira G, Cândido de Almeida D, Olsen Saraiva Camara N. Activation and Metabolic Shifting: An Essential Process to Mesenchymal Stromal Cells Function. Stem Cell Research [Working Title] 2022. [DOI: 10.5772/intechopen.109273] [Reference Citation Analysis]
11 Li W, Xu Y, Chen W. Bone mesenchymal stem cells deliver exogenous lncRNA CAHM via exosomes to regulate macrophage polarization and ameliorate intervertebral disc degeneration. Exp Cell Res 2022;421:113408. [PMID: 36334792 DOI: 10.1016/j.yexcr.2022.113408] [Reference Citation Analysis]
12 Ge X, Meng Q, Liu X, Liu J, Ma X, Shi S, Li M, Lin F, Liang X, Gong X, Liu Z, Han W, Zhou X. Alterations of long noncoding RNAs and mRNAs in extracellular vesicles derived from the murine heart post-ischemia-reperfusion injury. J Cell Mol Med 2022;26:6006-18. [PMID: 36444487 DOI: 10.1111/jcmm.17617] [Reference Citation Analysis]
13 Zhang J, Lu Y, Mao Y, Yu Y, Wu T, Zhao W, Zhu Y, Zhao P, Zhang F. IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-02984-z] [Reference Citation Analysis]
14 Abdolmohammadi K, Mahmoudi T, Alimohammadi M, Tahmasebi S, Zavvar M, Hashemi SM. Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation. Life Sci 2022;312:121206. [PMID: 36403645 DOI: 10.1016/j.lfs.2022.121206] [Reference Citation Analysis]
15 Fadaei S, Zarepour F, Parvaresh M, Motamedzadeh A, Tamehri Zadeh SS, Sheida A, Shabani M, Hamblin MR, Rezaee M, Zarei M, Mirzaei H. Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1014961] [Reference Citation Analysis]
16 Qing-Fang Han, Wen-Jia Li, Kai-Shun Hu, Jie Gao, Wen-Long Zhai, Jing-Hua Yang, Shui-Jun Zhang. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 2022;21:207. [PMID: 36320056 DOI: 10.1186/s12943-022-01671-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Fang J, Zhang Y, Chen D, Zheng Y, Jiang J. Exosomes and Exosomal Cargos: A Promising World for Ventricular Remodeling Following Myocardial Infarction. Int J Nanomedicine 2022;17:4699-719. [PMID: 36217495 DOI: 10.2147/IJN.S377479] [Reference Citation Analysis]
18 Ramasubramanian L, Du S, Gidda S, Bahatyrevich N, Hao D, Kumar P, Wang A. Bioengineering Extracellular Vesicles for the Treatment of Cardiovascular Diseases. Adv Biol (Weinh) 2022;6:e2200087. [PMID: 35778828 DOI: 10.1002/adbi.202200087] [Reference Citation Analysis]
19 Sharma V, Manhas A, Gupta S, Dikshit M, Jagavelu K, Verma RS. Fabrication, characterization and in vivo assessment of cardiogel loaded chitosan patch for myocardial regeneration. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.10.079] [Reference Citation Analysis]
20 Xie J, Hu Y, Sun D, Liu C, Li Z, Zhu J. Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases. Front Pharmacol 2022;13:978151. [DOI: 10.3389/fphar.2022.978151] [Reference Citation Analysis]
21 Ma J, Lei P, Chen H, Wang L, Fang Y, Yan X, Yang Q, Peng B, Jin L, Sun D. Advances in lncRNAs from stem cell-derived exosome for the treatment of cardiovascular diseases. Front Pharmacol 2022;13:986683. [DOI: 10.3389/fphar.2022.986683] [Reference Citation Analysis]
22 Femminò S, Bonelli F, Brizzi MF. Extracellular vesicles in cardiac repair and regeneration: Beyond stem-cell-based approaches. Front Cell Dev Biol 2022;10:996887. [DOI: 10.3389/fcell.2022.996887] [Reference Citation Analysis]
23 You B, Yang Y, Zhou Z, Yan Y, Zhang L, Jin J, Qian H. Extracellular Vesicles: A New Frontier for Cardiac Repair. Pharmaceutics 2022;14:1848. [DOI: 10.3390/pharmaceutics14091848] [Reference Citation Analysis]
24 Yi X, Chen J, Huang D, Feng S, Yang T, Li Z, Wang X, Zhao M, Wu J, Zhong T. Current perspectives on clinical use of exosomes as novel biomarkers for cancer diagnosis. Front Oncol 2022;12:966981. [DOI: 10.3389/fonc.2022.966981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Lu Y, Yang Y, Liu S, Ge S. Biomaterials constructed for MSC-derived extracellular vesicle loading and delivery—a promising method for tissue regeneration. Front Cell Dev Biol 2022;10:898394. [DOI: 10.3389/fcell.2022.898394] [Reference Citation Analysis]
26 Ahmed L, Al-Massri K. New Approaches for Enhancement of the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Diseases. Tissue Eng Regen Med 2022. [PMID: 35867309 DOI: 10.1007/s13770-022-00469-x] [Reference Citation Analysis]
27 Yedavilli S, Singh AD, Singh D, Samal R. Nano-Messengers of the Heart: Promising Theranostic Candidates for Cardiovascular Maladies. Front Physiol 2022;13:895322. [DOI: 10.3389/fphys.2022.895322] [Reference Citation Analysis]
28 Xiong Y, Tang R, Xu J, Jiang W, Gong Z, Zhang L, Ning Y, Huang P, Xu J, Chen G, Li X, Hu M, Xu J, Wu C, Jin C, Li X, Qian H, Yang Y. Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1/NF-κB p65 pathway. Stem Cell Res Ther 2022;13:289. [PMID: 35799283 DOI: 10.1186/s13287-022-02969-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Zhang X, Wu Y, Cheng Q, Bai L, Huang S, Gao J. Extracellular Vesicles in Cardiovascular Diseases: Diagnosis and Therapy. Front Cell Dev Biol 2022;10:875376. [DOI: 10.3389/fcell.2022.875376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Liu J, Zhang M, Qin C, Wang Z, Chen J, Wang R, Hu J, Zou Q, Niu X. Resveratrol Attenuate Myocardial Injury by Inhibiting Ferroptosis Via Inducing KAT5/GPX4 in Myocardial Infarction. Front Pharmacol 2022;13:906073. [DOI: 10.3389/fphar.2022.906073] [Reference Citation Analysis]
31 Toghiani R, Abolmaali SS, Najafi H, Tamaddon AM. Bioengineering exosomes for treatment of organ ischemia/reperfusion injury. Life Sci 2022;:120654. [PMID: 35597547 DOI: 10.1016/j.lfs.2022.120654] [Reference Citation Analysis]
32 Chen S, Sun F, Qian H, Xu W, Jiang J, Bruno S. Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Therapy. Stem Cells International 2022;2022:1-18. [DOI: 10.1155/2022/1779346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
33 Shokravi S, Borisov V, Zaman BA, Niazvand F, Hazrati R, Khah MM, Thangavelu L, Marzban S, Sohrabi A, Zamani A. Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review. Stem Cell Res Ther 2022;13:192. [PMID: 35527304 DOI: 10.1186/s13287-022-02825-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Lai J, Huang C, Guo Y, Rao L. Engineered extracellular vesicles and their mimics in cardiovascular diseases. J Control Release 2022;347:27-43. [PMID: 35508222 DOI: 10.1016/j.jconrel.2022.04.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Roohaninasab M, Yavari SF, Babazadeh M, Hagh RA, Pazoki M, Amrovani M. Evaluating the Role of lncRNAs in the Incidence of Cardiovascular Diseases in Androgenetic Alopecia Patients. Cardiovasc Toxicol 2022. [PMID: 35507254 DOI: 10.1007/s12012-022-09742-w] [Reference Citation Analysis]
36 Zheng YL, Wang WD, Cai PY, Zheng F, Zhou YF, Li MM, Du JR, Lin S, Lin HL. Stem cell-derived exosomes in the treatment of acute myocardial infarction in preclinical animal models: a meta-analysis of randomized controlled trials. Stem Cell Res Ther 2022;13:151. [PMID: 35395872 DOI: 10.1186/s13287-022-02833-z] [Reference Citation Analysis]
37 Joladarashi D, Kishore R. Mesenchymal Stromal Cell Exosomes in Cardiac Repair. Curr Cardiol Rep 2022;24:405-17. [PMID: 35092595 DOI: 10.1007/s11886-022-01660-1] [Reference Citation Analysis]
38 Kim HY, Kwon S, Um W, Shin S, Kim CH, Park JH, Kim BS. Functional Extracellular Vesicles for Regenerative Medicine. Small 2022;:e2106569. [PMID: 35322545 DOI: 10.1002/smll.202106569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Soler-botija C, Monguió-tortajada M, Munizaga-larroudé M, Gálvez-montón C, Bayes-genis A, Roura S. Mechanisms governing the therapeutic effect of mesenchymal stromal cell-derived extracellular vesicles: A scoping review of preclinical evidence. Biomedicine & Pharmacotherapy 2022;147:112683. [DOI: 10.1016/j.biopha.2022.112683] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
40 Zhou W, Feng Q, Cheng M, Zhang D, Jin J, Zhang S, Bai Y, Xu J. LncRNA H19 sponges miR-103-3p to promote the high phosphorus-induced osteoblast phenotypic transition of vascular smooth muscle cells by upregulating Runx2. Cellular Signalling 2022;91:110220. [DOI: 10.1016/j.cellsig.2021.110220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
41 Tan L, Liu X, Dou H, Hou Y. Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment — specific factors involved in the regulation of MSC plasticity. Genes & Diseases 2022;9:296-309. [DOI: 10.1016/j.gendis.2020.10.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
42 Chen H, Xue R, Huang P, Wu Y, Fan W, He X, Dong Y, Liu C. Modified Exosomes: a Good Transporter for miRNAs within Stem Cells to Treat Ischemic Heart Disease. J Cardiovasc Transl Res 2022. [PMID: 35229250 DOI: 10.1007/s12265-022-10216-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Liu Y, Guan R, Yan J, Zhu Y, Sun S, Qu Y. Mesenchymal Stem Cell-Derived Extracellular Vesicle-Shuttled microRNA-302d-3p Represses Inflammation and Cardiac Remodeling Following Acute Myocardial Infarction. J Cardiovasc Transl Res 2022. [PMID: 35194734 DOI: 10.1007/s12265-021-10200-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Yang L, Wang T, Zhang X, Zhang H, Yan N, Zhang G, Yan R, Li Y, Yu J, He J, Jia S, Wang H. Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis. BMC Cardiovasc Disord 2022;22:61. [PMID: 35172728 DOI: 10.1186/s12872-022-02508-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Xiao H, Wu D, Yang T, Fu W, Yang L, Hu C, Wan H, Hu X, Zhang C, Wu T. Extracellular vesicles derived from HBMSCs improved myocardial infarction through inhibiting zinc finger antisense 1 and activating Akt/Nrf2/HO-1 pathway. Bioengineered 2022;13:905-16. [PMID: 34974805 DOI: 10.1080/21655979.2021.2014389] [Reference Citation Analysis]
46 Alnasser S, Al-rasheedi M, Alreshidi MA, Alqifari SF, Haider KH. Augmenting Mesenchymal Stem Cell-Based Therapy of the Infarcted Myocardium with Statins. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_20-1] [Reference Citation Analysis]
47 Alnasser S, Al-rasheedi M, Alreshidi MA, Alqifari SF, Haider KH. Augmenting Mesenchymal Stem Cell-Based Therapy of the Infarcted Myocardium with Statins. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_20] [Reference Citation Analysis]
48 An Z, Tian J, Liu Y, Zhao X, Yang X, Yong J, Liu L, Zhang L, Jiang W, Song X, Zhang H. Exosomes as a Cell-free Therapy for Myocardial Injury Following Acute Myocardial Infarction or Ischemic Reperfusion. Aging and disease 2022;13:1770. [DOI: 10.14336/ad.2022.0416] [Reference Citation Analysis]
49 Haider KH, Najimi M. Exosome-Based Cell-Free Therapy in Regenerative Medicine for Myocardial Repair. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_42] [Reference Citation Analysis]
50 Haider KH, Najimi M. Exosome-Based Cell-Free Therapy in Regenerative Medicine for Myocardial Repair. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_42-1] [Reference Citation Analysis]
51 Hsu Y, Huang K, Cheng K. Resuscitating the Field of Cardiac Regeneration: Seeking Answers from Basic Biology. Adv Biol (Weinh) 2021;:e2101133. [PMID: 34939372 DOI: 10.1002/adbi.202101133] [Reference Citation Analysis]
52 Wang Q, Zhang L, Sun Z, Chi B, Zou A, Mao L, Xiong X, Jiang J, Sun L, Zhu W, Ji Y. HIF-1α overexpression in mesenchymal stem cell-derived exosome-encapsulated arginine-glycine-aspartate (RGD) hydrogels boost therapeutic efficacy of cardiac repair after myocardial infarction. Mater Today Bio 2021;12:100171. [PMID: 34901821 DOI: 10.1016/j.mtbio.2021.100171] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
53 Sun G, Shen JF, Wei XF, Qi GX. Circular RNA Foxo3 Relieves Myocardial Ischemia/Reperfusion Injury by Suppressing Autophagy via Inhibiting HMGB1 by Repressing KAT7 in Myocardial Infarction. J Inflamm Res 2021;14:6397-407. [PMID: 34880642 DOI: 10.2147/JIR.S339133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
54 Wang Y, Sun X, Sun X. The Functions of LncRNA H19 in the Heart. Heart Lung Circ 2021:S1443-9506(21)01343-3. [PMID: 34840062 DOI: 10.1016/j.hlc.2021.10.022] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Li C, Ni YQ, Xu H, Xiang QY, Zhao Y, Zhan JK, He JY, Li S, Liu YS. Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduct Target Ther 2021;6:383. [PMID: 34753929 DOI: 10.1038/s41392-021-00779-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
56 Lee C, Chen Y, Hsiao AW, Wang AY, Shen OY, Wang BY, Ho LWC, Lin W, Choi CHJ, Lee OK. Demystifying the long noncoding RNA landscape of small EVs derived from human mesenchymal stromal cells. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.11.003] [Reference Citation Analysis]
57 Zheng H, Liang X, Han Q, Shao Z, Zhang Y, Shi L, Hong Y, Li W, Mai C, Mo Q, Fu Q, Ma X, Lin F, Li M, Hu B, Li X, Zhang Y. Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence. J Nanobiotechnology 2021;19:332. [PMID: 34674708 DOI: 10.1186/s12951-021-01077-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
58 Han C, Yang J, Sun J, Qin G. Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications. Pharmacol Ther 2021;:108025. [PMID: 34687770 DOI: 10.1016/j.pharmthera.2021.108025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
59 Li X, Li N, Li B, Feng Y, Zhou D, Chen G. Noncoding RNAs and RNA-binding proteins in diabetic wound healing. Bioorg Med Chem Lett 2021;50:128311. [PMID: 34438011 DOI: 10.1016/j.bmcl.2021.128311] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Xu Z, Tian N, Li S, Li K, Guo H, Zhang H, Jin H, An M, Yu X. Extracellular vesicles secreted from mesenchymal stem cells exert anti-apoptotic and anti-inflammatory effects via transmitting microRNA-18b in rats with diabetic retinopathy. Int Immunopharmacol 2021;101:108234. [PMID: 34655847 DOI: 10.1016/j.intimp.2021.108234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
61 Pan Q, Xu J, Wen CJ, Xiong YY, Gong ZT, Yang YJ. Nanoparticles: Promising Tools for the Treatment and Prevention of Myocardial Infarction. Int J Nanomedicine 2021;16:6719-47. [PMID: 34621124 DOI: 10.2147/IJN.S328723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
62 Sun L, He X, Zhang T, Han Y, Tao G. Knockdown of mesenchymal stem cell‑derived exosomal LOC100129516 suppresses the symptoms of atherosclerosis via upregulation of the PPARγ/LXRα/ABCA1 signaling pathway. Int J Mol Med 2021;48:208. [PMID: 34608501 DOI: 10.3892/ijmm.2021.5041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Meng H, Cheng W, Wang L, Chen S, Teng Y, Lu Z, Li Y, Zhao M. Mesenchymal Stem Cell Exosomes in the Treatment of Myocardial Infarction: a Systematic Review of Preclinical In Vivo Studies. J Cardiovasc Transl Res 2021. [PMID: 34611844 DOI: 10.1007/s12265-021-10168-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
64 Xie L, Zhang Q, Mao J, Zhang J, Li L. The Roles of lncRNA in Myocardial Infarction: Molecular Mechanisms, Diagnosis Biomarkers, and Therapeutic Perspectives. Front Cell Dev Biol 2021;9:680713. [PMID: 34604208 DOI: 10.3389/fcell.2021.680713] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
65 Wang ZG, Xu HE, Cheng FM, Zhang J, Feng YH, Liu DH, Shang WJ, Feng GW. Donor BMSC-derived small extracellular vesicles relieve acute rejection post-renal allograft through transmitting Loc108349490 to dendritic cells. Aging Cell 2021;20:e13461. [PMID: 34499402 DOI: 10.1111/acel.13461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
66 Ning H, Chen H, Deng J, Xiao C, Xu M, Shan L, Yang C, Zhang Z. Exosomes secreted by FNDC5-BMMSCs protect myocardial infarction by anti-inflammation and macrophage polarization via NF-κB signaling pathway and Nrf2/HO-1 axis. Stem Cell Res Ther 2021;12:519. [PMID: 34583757 DOI: 10.1186/s13287-021-02591-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
67 Wang C, Xing C, Li Z, Liu Y, Li Q, Wang Y, Hu J, Yuan L, Yang G. Bioinspired therapeutic platform based on extracellular vesicles for prevention of arterial wall remodeling in hypertension. Bioact Mater 2022;8:494-504. [PMID: 34541415 DOI: 10.1016/j.bioactmat.2021.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
68 Guo J, Yang Z, Wang X, Xu Y, Lu Y, Qin Z, Zhang L, Xu J, Wang W, Zhang J, Tang J. Advances in Nanomaterials for Injured Heart Repair. Front Bioeng Biotechnol 2021;9:686684. [PMID: 34513807 DOI: 10.3389/fbioe.2021.686684] [Reference Citation Analysis]
69 Chen R, Lei S, She Y, Zhou S, Shi H, Li C, Jiang T. Lnc-GD2H Promotes Proliferation by Forming a Feedback Loop With c-Myc and Enhances Differentiation Through Interacting With NACA to Upregulate Myog in C2C12 Myoblasts. Front Cell Dev Biol 2021;9:671857. [PMID: 34490239 DOI: 10.3389/fcell.2021.671857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Zhao T, Wu W, Sui L, Huang Q, Nan Y, Liu J, Ai K. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioact Mater 2022;7:47-72. [PMID: 34466716 DOI: 10.1016/j.bioactmat.2021.06.006] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 30.0] [Reference Citation Analysis]
71 Wu R, Hu W, Chen H, Wang Y, Li Q, Xiao C, Fan L, Zhong Z, Chen X, Lv K, Zhong S, Shi Y, Chen J, Zhu W, Zhang J, Hu X, Wang J. A Novel Human Long Noncoding RNA SCDAL Promotes Angiogenesis through SNF5-Mediated GDF6 Expression. Adv Sci (Weinh) 2021;8:e2004629. [PMID: 34319658 DOI: 10.1002/advs.202004629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
72 Gu X, Shi Y, Dong M, Jiang L, Yang J, Liu Z. Exosomal transfer of tumor-associated macrophage-derived hsa_circ_0001610 reduces radiosensitivity in endometrial cancer. Cell Death Dis 2021;12:818. [PMID: 34462422 DOI: 10.1038/s41419-021-04087-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
73 Bär C, Chatterjee S, Falcão Pires I, Rodrigues P, Sluijter JPG, Boon RA, Nevado RM, Andrés V, Sansonetti M, de Windt L, Ciccarelli M, Hamdani N, Heymans S, Figuinha Videira R, Tocchetti CG, Giacca M, Zacchigna S, Engelhardt S, Dimmeler S, Madonna R, Thum T. Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. Cardiovasc Res 2020;116:1805-19. [PMID: 32638021 DOI: 10.1093/cvr/cvaa195] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
74 Wang L, Qi L. The role and mechanism of long non-coding RNA H19 in stem cell osteogenic differentiation. Mol Med 2021;27:86. [PMID: 34384352 DOI: 10.1186/s10020-021-00350-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Panda B, Sharma Y, Gupta S, Mohanty S. Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine: A Comprehensive Review. Life (Basel) 2021;11:784. [PMID: 34440528 DOI: 10.3390/life11080784] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
76 Escudé Martinez de Castilla P, Tong L, Huang C, Sofias AM, Pastorin G, Chen X, Storm G, Schiffelers RM, Wang JW. Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies. Adv Drug Deliv Rev 2021;175:113801. [PMID: 34015418 DOI: 10.1016/j.addr.2021.05.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
77 Hade MD, Suire CN, Suo Z. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine. Cells 2021;10:1959. [PMID: 34440728 DOI: 10.3390/cells10081959] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 15.5] [Reference Citation Analysis]
78 Wang Y, Chen J, Cowan DB, Wang DZ. Non-coding RNAs in cardiac regeneration: Mechanism of action and therapeutic potential. Semin Cell Dev Biol 2021:S1084-9521(21)00194-4. [PMID: 34284952 DOI: 10.1016/j.semcdb.2021.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
79 Yuan Z, Huang W. New Developments in Exosomal lncRNAs in Cardiovascular Diseases. Front Cardiovasc Med 2021;8:709169. [PMID: 34307511 DOI: 10.3389/fcvm.2021.709169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
80 Huang LH, Rau CS, Wu SC, Wu YC, Wu CJ, Tsai CW, Lin CW, Lu TH, Hsieh CH. Identification and characterization of hADSC-derived exosome proteins from different isolation methods. J Cell Mol Med 2021;25:7436-50. [PMID: 34235869 DOI: 10.1111/jcmm.16775] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
81 Ghafouri-Fard S, Niazi V, Hussen BM, Omrani MD, Taheri M, Basiri A. The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes. Front Cell Dev Biol 2021;9:653296. [PMID: 34307345 DOI: 10.3389/fcell.2021.653296] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
82 Shi X, Jiang N, Mao J, Luo D, Liu Y. Mesenchymal stem cell‐derived exosomes for organ development and cell‐free therapy. Nano Select 2021;2:1291-1325. [DOI: 10.1002/nano.202000286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Huang Y, Zhang X, Zhan J, Yan Z, Chen D, Xue X, Pan X. Bone marrow mesenchymal stem cell-derived exosomal miR-206 promotes osteoblast proliferation and differentiation in osteoarthritis by reducing Elf3. J Cell Mol Med 2021;25:7734-45. [PMID: 34160894 DOI: 10.1111/jcmm.16654] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
84 Davidson SM, Padró T, Bollini S, Vilahur G, Duncker DJ, Evans PC, Guzik T, Hoefer IE, Waltenberger J, Wojta J, Weber C. Progress in cardiac research - from rebooting cardiac regeneration to a complete cell atlas of the heart. Cardiovasc Res 2021:cvab200. [PMID: 34114614 DOI: 10.1093/cvr/cvab200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
85 Chingale M, Zhu D, Cheng K, Huang K. Bioengineering Technologies for Cardiac Regenerative Medicine. Front Bioeng Biotechnol 2021;9:681705. [PMID: 34150737 DOI: 10.3389/fbioe.2021.681705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
86 Wang X, Tang Y, Liu Z, Yin Y, Li Q, Liu G, Yan B. The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction. Stem Cells Int 2021;2021:5579904. [PMID: 34122557 DOI: 10.1155/2021/5579904] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
87 Liu M, López de Juan Abad B, Cheng K. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev 2021;173:504-19. [PMID: 33831476 DOI: 10.1016/j.addr.2021.03.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
88 Wang SH, Zhu XL, Wang F, Chen SX, Chen ZT, Qiu Q, Liu WH, Wu MX, Deng BQ, Xie Y, Mai JT, Yang Y, Wang JF, Zhang HF, Chen YX. LncRNA H19 governs mitophagy and restores mitochondrial respiration in the heart through Pink1/Parkin signaling during obesity. Cell Death Dis 2021;12:557. [PMID: 34050133 DOI: 10.1038/s41419-021-03821-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
89 Hu Y, Tao R, Chen L, Xiong Y, Xue H, Hu L, Yan C, Xie X, Lin Z, Panayi AC, Mi B, Liu G. Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis. J Nanobiotechnology 2021;19:150. [PMID: 34020670 DOI: 10.1186/s12951-021-00894-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 14.0] [Reference Citation Analysis]
90 Tsilimigras DI, Bibli SI, Siasos G, Oikonomou E, Perrea DN, Filis K, Tousoulis D, Sigala F. Regulation of Long Non-Coding RNAs by Statins in Atherosclerosis. Biomolecules 2021;11:623. [PMID: 33922114 DOI: 10.3390/biom11050623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Li J, Hu S, Zhu D, Huang K, Mei X, López de Juan Abad B, Cheng K. All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart. J Am Heart Assoc 2021;10:e020402. [PMID: 33821664 DOI: 10.1161/JAHA.120.020402] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
92 Hu S, Li Z, Shen D, Zhu D, Huang K, Su T, Dinh PU, Cores J, Cheng K. Exosome-eluting stents for vascular healing after ischaemic injury. Nat Biomed Eng 2021. [PMID: 33820981 DOI: 10.1038/s41551-021-00705-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 23.0] [Reference Citation Analysis]
93 Bano S, Tandon S, Tandon C. Emerging role of exosomes in arterial and renal calcification. Hum Exp Toxicol 2021;40:1385-402. [PMID: 33739177 DOI: 10.1177/09603271211001122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Zhu D, Cheng K. Cardiac Cell Therapy for Heart Repair: Should the Cells Be Left Out? Cells 2021;10:641. [PMID: 33805763 DOI: 10.3390/cells10030641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
95 Zhu W, Sun L, Zhao P, Liu Y, Zhang J, Zhang Y, Hong Y, Zhu Y, Lu Y, Zhao W, Chen X, Zhang F. Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p. J Nanobiotechnology 2021;19:61. [PMID: 33639970 DOI: 10.1186/s12951-021-00808-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
96 Saludas L, Oliveira CC, Roncal C, Ruiz-Villalba A, Prósper F, Garbayo E, Blanco-Prieto MJ. Extracellular Vesicle-Based Therapeutics for Heart Repair. Nanomaterials (Basel) 2021;11:570. [PMID: 33668836 DOI: 10.3390/nano11030570] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
97 Ghodrat S, Hoseini SJ, Asadpour S, Nazarnezhad S, Alizadeh Eghtedar F, Kargozar S. Stem cell-based therapies for cardiac diseases: The critical role of angiogenic exosomes. Biofactors 2021;47:270-91. [PMID: 33606893 DOI: 10.1002/biof.1717] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
98 Hashemzadeh MR, Taghavizadeh Yazdi ME, Amiri MS, Mousavi SH. Stem cell therapy in the heart: Biomaterials as a key route. Tissue Cell 2021;71:101504. [PMID: 33607524 DOI: 10.1016/j.tice.2021.101504] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
99 Nguyen BY, Azam T, Wang X. Cellular signaling cross-talk between different cardiac cell populations: an insight into the role of exosomes in the heart diseases and therapy. Am J Physiol Heart Circ Physiol 2021;320:H1213-34. [PMID: 33513083 DOI: 10.1152/ajpheart.00718.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
100 Xiong YY, Gong ZT, Tang RJ, Yang YJ. The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction. Theranostics 2021;11:1046-58. [PMID: 33391520 DOI: 10.7150/thno.53326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 14.5] [Reference Citation Analysis]
101 Ortega A, Martinez-Arroyo O, Forner MJ, Cortes R. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus. Pharmaceutics 2020;13:E3. [PMID: 33374908 DOI: 10.3390/pharmaceutics13010003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
102 Yu YW, Xue YJ, Qian LL, Chen Z, Que JQ, Huang KY, Liu S, Weng YB, Rong FN, Ji KT, Zeng JN. Screening and Identification of Potential Hub Genes in Myocardial Infarction Through Bioinformatics Analysis. Clin Interv Aging 2020;15:2233-43. [PMID: 33293800 DOI: 10.2147/CIA.S281290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
103 Li J, Yao Z, Xiong H, Cui H, Wang X, Zheng W, Qian Y, Fan C. Extracellular vesicles from hydroxycamptothecin primed umbilical cord stem cells enhance anti-adhesion potential for treatment of tendon injury. Stem Cell Res Ther 2020;11:500. [PMID: 33239069 DOI: 10.1186/s13287-020-02016-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
104 Stine SJ, Popowski KD, Su T, Cheng K. Exosome and Biomimetic Nanoparticle Therapies for Cardiac Regenerative Medicine. Curr Stem Cell Res Ther 2020;15:674-84. [PMID: 32148200 DOI: 10.2174/1574888X15666200309143924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
105 Zhuang L, Xia W, Chen D, Ye Y, Hu T, Li S, Hou M. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p. J Nanobiotechnology 2020;18:157. [PMID: 33129330 DOI: 10.1186/s12951-020-00716-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
106 Videira RF, da Costa Martins PA. Non-coding RNAs in Cardiac Intercellular Communication. Front Physiol 2020;11:738. [PMID: 33013428 DOI: 10.3389/fphys.2020.00738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
107 Huang G, Garikipati VNS, Zhou Y, Benedict C, Houser SR, Koch WJ, Kishore R. Identification and Comparison of Hyperglycemia-Induced Extracellular Vesicle Transcriptome in Different Mouse Stem Cells. Cells 2020;9:E2098. [PMID: 32942572 DOI: 10.3390/cells9092098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
108 Yu M, Liu W, Li J, Lu J, Lu H, Jia W, Liu F. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. Stem Cell Res Ther. 2020;11:350. [PMID: 32787917 DOI: 10.1186/s13287-020-01824-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 70] [Article Influence: 21.0] [Reference Citation Analysis]
109 Huang Y. Exosomal lncRNAs from mesenchymal stem cells as the novel modulators to cardiovascular disease. Stem Cell Res Ther 2020;11:315. [PMID: 32703265 DOI: 10.1186/s13287-020-01812-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
110 Pham TP, Boon RA. Exosomes and non-coding RNA, the healers of the heart? Cardiovasc Res 2020;116:258-9. [PMID: 31321404 DOI: 10.1093/cvr/cvz190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
111 Liang B, He X, Zhao YX, Zhang XX, Gu N. Advances in Exosomes Derived from Different Cell Sources and Cardiovascular Diseases. Biomed Res Int 2020;2020:7298687. [PMID: 32724810 DOI: 10.1155/2020/7298687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
112 Deng B, Zhang X, Liang Y, Jiang H, Huang W, Wu Y, Deng W. Nonadherent culture method promotes MSC-mediated vascularization in myocardial infarction via miR-519d/VEGFA pathway. Stem Cell Res Ther 2020;11:266. [PMID: 32616068 DOI: 10.1186/s13287-020-01780-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
113 Liu W, Yu M, Xie D, Wang L, Ye C, Zhu Q, Liu F, Yang L. Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020;11:259. [PMID: 32600435 DOI: 10.1186/s13287-020-01756-x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 105] [Article Influence: 32.3] [Reference Citation Analysis]
114 Li J, Wang M, Chen X. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia. Cell Cycle 2020;19:1454-65. [PMID: 32286143 DOI: 10.1080/15384101.2020.1750814] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
115 Balbi C, Costa A, Barile L, Bollini S. Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation. Cells 2020;9:E724. [PMID: 32183455 DOI: 10.3390/cells9030724] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
116 Guo Y, Chen J, Qiu H. Novel Mechanisms of Exercise-Induced Cardioprotective Factors in Myocardial Infarction. Front Physiol 2020;11:199. [PMID: 32210839 DOI: 10.3389/fphys.2020.00199] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
117 Chen H, Xia W, Hou M. LncRNA-NEAT1 from the competing endogenous RNA network promotes cardioprotective efficacy of mesenchymal stem cell-derived exosomes induced by macrophage migration inhibitory factor via the miR-142-3p/FOXO1 signaling pathway. Stem Cell Res Ther 2020;11:31. [PMID: 31964409 DOI: 10.1186/s13287-020-1556-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
118 Li WQ, Wu JY, Xiang DX, Luo SL, Hu XB, Tang TT, Sun TL, Liu XY. Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis. Int J Nanomedicine 2019;14:8345-60. [PMID: 31695371 DOI: 10.2147/IJN.S219670] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
119 Caccioppo A, Franchin L, Grosso A, Angelini F, D'Ascenzo F, Brizzi MF. Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration. Int J Mol Sci 2019;20:E5024. [PMID: 31614414 DOI: 10.3390/ijms20205024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
120 Lutz H, Hu S, Dinh P, Cheng K. Cells and cell derivatives as drug carriers for targeted delivery. Medicine in Drug Discovery 2019;3:100014. [DOI: 10.1016/j.medidd.2020.100014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]